Cytogenetic and Molecular Genetic Studies in Bone Sarcomas



Status:Completed
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:December 1993
End Date:February 2016

Use our guide to learn which trials are right for you!

To establish a serial ascertainement of specimens from patients with bone sarcomas to be
used in ongoing cytogenetic and molecular genetic analyses. These data will be integrated
and correlated with the established Orthopaedic Service clinical database.


Inclusion Criteria:

- Patients must be undergoing diagnostic biopsy or resection of their primary or
metastatic bone sarcoma for therapeutic purposes.

- The specimen must be large enough to allow routine pathological analysis, with the
specimen for research excised from residual tissue that would otherwise be discarded.

Exclusion Criteria:
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials